Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women

Montefiore Medicine Academic Health System

Status and phase: Terminated; Phase 2; Phase 1

Conditions: Pain

Treatments: Drug: Placebo; Drug: Ropivacaine 0.5% 20cc injectate bilaterally

Study type: Interventional

Funder types: Other

Identifiers

NCT01866917

12-11-397

Details and patient eligibility

About

Study the effect of the Transversis Abdominis Plane (TAP) block on pain after surgery for obese women undergoing laparoscopic or robotic gynecologic procedures.

Enrollment: 35 patients

Sex: Female

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• BMI greater than or equal to 30, women undergoing laparoscopic or robotic in-patient procedures

Exclusion criteria

• Conversions, non-obese women

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

35 participants in 2 patient groups, including a placebo group

TAP

Experimental group

Description:

Patients will receive Ropivicaine 0.5% 20cc injectate from a study labeled syringe

Treatment:

Drug: Ropivacaine 0.5% 20cc injectate bilaterally

Saline

Placebo Comparator group

Description:

Patients will receive Normal saline 20cc injectate from a study labeled syringe

Treatment:

Drug: Placebo